Press
June 6, 2024 | Gilead Announcement
Gilead made a formal external announcement on Twitter/X for Pride Month titled “Advancing LGBTQ+ Clinical Trial Representation,” which reached over 11.6 thousand views. Thank you, Gilead! Visit the announcement here.
June 6, 2024 | BioSpace Press Release
BioSpace wrote an announcement about SGM Alliance’s call to action during Pride Month in an article titled “SGM Alliance Announces Global Collaboration and Call to Action to Address LGBTQIA+ Representation Issues in Clinical Studies.” Visit the press release here.
June 11, 2024 | Bay Area Reporter Article
John Ferrannini, editor of the Bay Area Reporter, wrote an article titled “LGBTQ Agenda: Companies Working on Lifting Restrictions on HIV-Positive People in Clinical Trials,” tailored for San Francisco readers. Ferrannini coupled his article with an interview with Dr. Tom Uldrick, deputy head of global oncology at the Fred Hutchinson Cancer Center in Seattle, for an interesting perspective. Visit the article here.
June 20, 2024 | Dallas Voice Article
Tammye Nash, editor of the Dallas Voice, wrote an article on our press release titled “SGM Alliance Announces Call to Action to Address Presentation Issues in Clinical Studies.” Visit the article here.
LinkedIn Announcements
- Eli Lilly’s Executive Vice President and President of Lilly Neuroscience made an announcement. Visit it here.
- Pfizer’s Senior Vice President of Clinical Development Operations made a shout-out. Visit it here.
- Darryl Sleep, Head of Global Public Health with Amgen, made a public announcement. Visit it here.
- Tarra Shingler, Chief Commercial Officer of StudyKIK, stood in solidarity with her shout-out. Visit it here.
